TrialHaematologica2022

T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial.

Lisa Blixt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.